Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Ezetimbe and milk of magnesia?How do iron rich plants influence lipitor's potency?Famotidine api patent expiry date?Picture life cycle management in pharma?Buy accutane onlypharmacies?
See the DrugPatentWatch profile for Auryxia
Auryxia is used to treat high phosphate levels (hyperphosphatemia) in people with chronic kidney disease (CKD). It helps lower phosphate by binding dietary phosphate in the gut so less is absorbed.
Auryxia is used in CKD-related hyperphosphatemia, including patients on dialysis and those not on dialysis, depending on prescribing information and local labeling.
No. Even though Auryxia contains iron, its primary approved use is phosphate control in CKD, not treatment of anemia or iron-deficiency conditions.
When phosphate remains high, it can contribute to mineral and bone disorders in CKD. Lowering phosphate is part of managing the complications of CKD-related mineral imbalance.
Other Questions About Auryxia :